Payments processing company EML is the target of a shareholder class action investigation over its alleged failure to timely alert the market to concerns about its money laundering risk and control systems.
Ben Roberts-Smith sues ex-wife ahead of defamation trial over war crimes allegations
Court urged to reject law firm’s contingency fee bid in ANZ, Westpac class actions
Tyro faces second class action investigation over terminal outage
Bigger is better for Johnson Winter & Slattery energy superstar George Croft
Kraft to pay Bega $9.25M to resolve peanut butter trade dress battle
Phoenix Institute files lawsuit accusing directors of duty breaches
Court to hear challenge to unions funding class action against UGL
Judge warns ‘enough’s enough’ in fight for damages over delayed Abilify generic
A judge has given Generic Health more time to file its evidence in a multimillion-dollar dispute with drug makers Otsuka and Bristol-Myers Squibbs over the delayed launch of generic versions of their antipsychotic drug Abilify, but warned there had to be a cut-off point for preparing the decade-long dispute for trial.